Bionexus Gene Lab CORP Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
BioNexus Gene Lab Corp. CEO Su-Leng Tan Lee received a stock-based award of 338,709 shares as compensation for services, increasing beneficial ownership to 11.5%.